Wednesday, October 20, 2021

Cipla

Editorial: Expand the vaccine basket

The Centre must speed up negotiations with foreign companies towards the removal of stumbling blocks to expand coverage

Cipla gets DCGI nod to import Moderna vaccine for emergency use

Moderna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik

Cipla gets USFDA nod for inhalation product

The company has received final approval for its abbreviated new drug application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL from the United States Food and Drug Administration (US FDA), Cipla said

Yashoda Hospitals launches antibody cocktail drugs to treat Covid

The first batch of Covid positive patients were administered with the antibody cocktail at Yashoda Hospital Secunderabad on Wednesday

Cipla launches rapid antigen test for Covid-19 diagnosis

The test is a rapid point-of-care nasopharyngeal swab test that directly detects the presence or absence of coronavirus antigen in the patient's body, generating results within 15-20 minutes.

Latest News

- Advertisement -